KIAA1524 Antikörper
-
- Target Alle KIAA1524 Antikörper anzeigen
- KIAA1524
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KIAA1524 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human KIAA1524 (NP_065941.2).
- Isotyp
- IgG
- Top Product
- Discover our top product KIAA1524 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KIAA1524
- Andere Bezeichnung
- KIAA1524 (KIAA1524 Produkte)
- Hintergrund
- Protein CIP2Aalso known ascancerous inhibitor of PP2A(CIP2A) is aproteinthat in humans is encoded by theKIAA1524gene. Protein phosphatase 2A (PP2A) is a cellular tumor suppressor which inhibits cell proliferation and transformation of normal cells to malignant cancer cells. Inhibition of PP2A activity is a prerequisite for human cell transformation. However, the in vivo mechanisms by which PP2A activity is inhibited in spontaneously transformed human cancer cells have been unclear.
- Molekulargewicht
-
Observed_MW: 102kDa
Calculated_MW: 84kDa/102kDa
- Gen-ID
- 57650
- UniProt
- Q8TCG1
-